Key Financial’s Avalo Therapeutics AVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding AVTX
Key Financial's AVTX Position: Q3 2026 in Review
Key Financial held its Avalo Therapeutics (AVTX) position steady in Q3 2026 at 1 share worth $15. The position accounts for ﹤0.01% of the portfolio, ranked #1305.
Key Financial first reported a position in AVTX in Q2 2024 and has held it in 10 quarters since. The position peaked at $18 in Q2 2026. 88 funds tracked by Wall St. Rank hold AVTX as of Q3 2026.
- Key Financial held 1 share of Avalo Therapeutics worth $15 as of Q3 2026.
- Key Financial left its Avalo Therapeutics share count unchanged in Q3 2026.
- Avalo Therapeutics made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1305 holding.
- Key Financial first reported a position in Avalo Therapeutics in Q2 2024 and has held it in 10 quarters since.
- Key Financial's Avalo Therapeutics position peaked at $18 in Q2 2026.
- 88 funds tracked by Wall St. Rank held Avalo Therapeutics as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.